Tamiflu (Oseltamivir)


February 20, 2006. Martin Terberger, European Commission Enterprice and Industry Directorate General. Letter to the European Generic Medicines Association on Tamiflu and Data Exclusivity.

February 13, 2006. Canadian generic pharmaceutical firm Biolyse asks its government to add Osteltamivir be added to its list of pharmaceutical products eligible for compulsory licensing for export. See the Letter to Health Minister Tony Abbott and Minister of Industry Maxime Bernier.

Page Index

CPTech Documents
WTO Rules on Compulsory Licenses and Exports
Roche Statements on Licensing
Gilead/Roche Licensing Dispute over Tamiflu
U.S. Government Documents
NGO Documents
Licensing Controversies by Country
Miscellaneous Documents
General News Stories

CPTech Documents

WTO Rules on Compulsory Licenses and Exports
Roche Statements on Licensing of Tamiflu
Gilead/Roche Licensing Dispute over Tamiflu
  • November 16, 2005. Associated Press. Roche, Gilead End Tamiflu Dispute - Agreement Is Part of Effort To Build Up Stocks of Flu Drug.
  • November 16, 2005. Agence France Presse. Roche, Gilead Tamiflu dispute resolved; revised deal agreed.

    E.U. Documents

    U.S. Government Documents

    NGO Documents

    Licensing Controversies by Country

  • South Korea

    Miscellaneous

    General News Stories


    Return to: CPTech Home -> Main IP Page -> IP and Healthcare -> Compulsory Licensing